• Despite a high interest rate environment, Hamptons-based real estate has shown remarkable resilience over the past year
• Median home sales prices in the Hamptons rose by 1.7% in 2023
• Mountain Top has partnered with On Site Builder Construction, a long-standing and reputed Hamptons-based developer to construct and market turnkey residential properties within the exclusive seaside enclave

Against a backdrop of slowing economic growth, rising interest rates and weak consumer sentiment, it comes as no surprise that the U.S. housing market was largely on hold in 2023. Residential transactions were forecast to have fallen by 37 percent in 2023, with commercial real estate suffering an even steeper decline in transaction volumes (https://ibn.fm/22gvk). Nonetheless and against that rather lackluster backdrop, one geography did stand out. Despite seeing a decline in year over year transaction volumes, median home sales prices across The Hamptons displayed remarkable resilience, rising by just under 2 percent in 2023 (https://ibn.fm/FsUzK).

The Hamptons has long been renowned for its high-end real estate market; notably, it was this very segment of the market which showed the most resilience over the past year. Despite seeing a 26 percent decline in year over year sales of individual properties, homes priced between $1 million and $3.5 million – which have historically accounted for the lion share of Hamptons’ property transactions, only witnessed a 21 percent decline.

It is this very resilience which Mountain Top Properties (OTC: MTPP), a diversified real estate holding company focused around building, acquiring, marketing and operating assets through its wholly owned affiliates, is looking to tap into. Through its Mountain Top Capital Fund I, Mountain Top Realty has sought to raise $75 million to acquire, renovate and remarket homes in the Hamptons; in recent weeks, the company has revealed plans to conduct a Regulation A offering, which will seek to raise up to $10 million in gross proceeds, destined to be deployed in support of the company’s real estate development plans. This will come on top of the fund’s existing debt capital foray, which has seen the fund receive commitments amounting to 70 percent of their anticipated real estate acquisition costs as well as a further 100 percent of the planned construction costs, a figure which the company will seek to complement with their upcoming equity raising exercise.

Mountain Top Realty will partner with On Site Builder Construction Co. Inc., as their design partner in their ambitious Hamptons-focused endeavor (https://ibn.fm/mMtm8). Having built over 60 custom-designed homes in the seaside enclave over the past several decades, On Site Builder Construction have gained a well-earnt reputation for designing and building some of the Hamptons’ highest quality over the past four decades, custom homes spanning a broad plethora of architectural styles – ranging from classic homes through to ultra-modern, glass-encased seaside mansions.

In recent years, On Site Builder Construction have the distinction of constructing and selling the Hampton’s most expensive properties in both, 2019 and 2022 – the latter at a remarkable $118,500,000 price point. Both companies will now seek to leverage upon this outstanding track record in the construction of exclusive, readymade turnkey properties for discerning Hamptons real estate investors.

For more information, visit the company’s website at www.Mountain-Top-Properties.com.

NOTE TO INVESTORS: The latest news and updates relating to MTPP are available in the company’s newsroom at https://ibn.fm/MTPP

• EV sales remain strong, projected to grow in 2024
• Mullen is positioning itself in the global market with recent purchase order from Grupo Cavel in the Dominican Republic
• Mullen EVs “establish a new level of quality among commercial vehicles,” says Cavel CEO

Electric vehicle sales are projected to continue growing globally in 2024, according to a recent NASDAQ report (https://ibn.fm/asZpm). That is great news for Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer that is expanding into the Caribbean market with its commercial CAMPUS EV cargo van (https://ibn.fm/Oph51).

“It’s important to note that EV sales are expected to continue growing in 2024,” stated the NASDAQ article. “In fact, EV sales have grown throughout 2023 — even though numerous headlines claimed that they have been falling in recent months.

“The reality is that EV sales remain strong and growing, although the supply of unsold EVs on dealer lots has increased,” the article continued. “In fact, the third quarter saw the strongest year-over-year growth in sales of battery-electric vehicles and plug-in hybrids since the fourth quarter of 2021. Additionally, EV sales surpassed one million for the first time in September.”

Additional sources concur. “Global sales of plug-in cars are expected to grow by 21 percent this year, according to Bloomberg New Energy Finance,” reported a Yale Environment 360 article (https://ibn.fm/2UrhM). “Analysts project sales will total 16.7 million worldwide, including 1.9 million plug-in cars sold in the U.S., 3.4 million in Europe, and 9.7 million in China.

Mullen is positioning itself in this global market with a recent purchase order from Grupo Cavel. The initial vehicle order is for 20 Mullen CAMPUS EV cargo vans to be sold by Cavel’s Electric Motors dealerships throughout the Dominican Republic and the Caribbean. The battery-operated Mullen CAMPUS cargo van is designed as an ideal delivery solution for micro-environments.

“Cavel plans to continue ongoing vehicle orders and will be establishing a sales and service distribution channel for Mullen’s lineup of commercial EVs in the Dominican Republic and Caribbean,” Mullen announced.

Grupo Cavel is a well-known retail automotive group in the Dominican Republic, which boasts the most electric vehicles per capita in Latin America countries. Cavel has also established key relationships in vehicle sales, distribution, warranty and servicing throughout the Caribbean.

“Our commitment to electric vehicles began with the introduction of the first electric motorcycles in the Dominican Republic, which grew into offering five brands through our Electric Motors dealerships,” said Grupo Cavel CEO Joel Tavarez. “Today we made an important decision by adding Mullen’s commercial vehicles to our portfolio. The Mullen EVs establish a new level of quality among commercial vehicles, and we are confident they will excel in the Dominican Republic and the broader region.”

Mullen CEO David Michery stated: “This is an important relationship for Mullen with a strong partner in Grupo Cavel, opening doors to a new market in the Dominican Republic and Caribbean, where the warm weather also provides a near-perfect operating environment for EVs.”

Mullen Automotive (NASDAQ: MULN) is a Southern California-based automotive company building the next generation of electric vehicles in its two United States-based manufacturing and assembly plants. Mullen’s EV development portfolio includes the Mullen FIVE Crossover and FIVE RS High-Performance Sport Crossover EVs, Mullen GT and GTRS EV Supercars, Mullen PowerUP Mobile EV Charging Truck, Mullen-GO Commercial Urban Delivery EV, Mullen Commercial Class 1-3 EVs, and Bollinger Motors, which features the B1 and B2 electric SUV trucks and Class 4-6 commercial offerings. On Sept. 7, 2022, Bollinger Motors became a majority-owned EV truck company of Mullen Automotive, and on Dec. 1, 2022, Mullen closed on the acquisition of all Electric Last Mile Solutions (“ELMS”) assets, including all IP and a 650,000-square-foot plant in Mishawaka, Indiana.

For more information about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

• The Venture Debt Conference is set for March 6, 2024, at the Edison Ballroom in Manhattan
• Now in its second year, this is the largest forum dedicated to non-dilutive financing strategies for emerging growth companies
• The conference also explores various forms of financing available to start-ups, including term loans, revenue-based financing, receivables financing and equipment financing, among others

Venture debt has rapidly grabbed attention as an attractive complement to venture capital funding for fast-growing start-ups. A catch-all term for loans designed to meet the unique needs of venture-backed start-ups in the innovation economy, venture debt has gained increasing popularity as a financing option for founders seeking to extend their runway, lower the cost of capital and most importantly, to thrive.

Venture debt can provide companies with an increased funding runway without the same level of dilution as an equity raise; better still, it is capital that founders can often employ to accelerate growth, achieve milestones and cover costs until a future funding round is successfully completed.

With over 20 years of experience and having hosted over 200 conferences, seminars and webcasts on a variety of financial topics, DealFlow Events is gearing up to host the second annual Venture Debt Conference, set for March 6, 2024 in New York City. A full-day forum designed to address the growing interest in venture debt as a complement to venture capital, the Venture Debt Conference will provide corporate executives with a closer look at these alternative financing options.

This event attracts a wide array of attendees, including speciality lending companies, commercial banks, family offices, and emerging growth companies.

The Venture Debt Conference will explore a key funding channel that has grown by more than 400% between 2012 and 2022. In addition to diving into the benefits of debt financing for both traditional and nonbank lenders, the forum will evaluate common venture debt loan products and terms, analyse new entrants in the market and their various strategies, delve into the changing requirements from corporate borrowers, as well as focusing on the ultimate impact of these loans.

This year’s forum features a number of keynote presentations from experts in the field, including the ‘State of the Venture Debt Market’; ‘Why is Venture Debt a Terrible Idea?’; ‘Cross-Border Venture Debt Deals’; and ‘Navigating Distress in Venture Debt’.

Speakers include Warren Biro, Partner at Barnes & Thornburg; Dan Devorsetz, COO at Horizon Technology Finance; Tyler Dietrich, Managing Director at Silicon Valley Bank; and Randy Garg, Founder at Vistara Growth, among several others.

For additional details about the Venture Debt Conference, including registration, visit: www.VentureDebtConference.com.

• Astiva Health’s culturally inclusive approach sets a new precedent in the Medicare Advantage market
• Enrollment in Medicare Advantage programs is projected to encompass half of all Medicare enrollments by 2024, with Astiva Health leading the charge in service expansion and inclusivity
• Astiva Health is committed to reshaping healthcare delivery with increased access to quality healthcare for diverse populations

In a landscape where more individuals are becoming eligible for Medicare, Astiva Health is carving out a niche as a rapidly growing Medicare Advantage Prescription Drug (“MAPD”) health plan. Astiva stands out by redefining personalized and comprehensive healthcare standards. Reflecting its success, Astiva recently celebrated surpassing the 10,000-member milestone (https://ibn.fm/qawEI).

“Projected increases from 31.6 million in 2023 to 33.8 million in 2024 in Medicare Advantage enrollment show that nearly half of all Medicare enrollees will choose Advantage plans,” according to a CMS release (https://ibn.fm/mtTsb).

“These statistics underscore the demand for robust and stable healthcare options,” added CMS Deputy Administrator Meena Seshamani, MD, PhD.

Astiva is at the forefront, offering robust solutions to those seeking quality Medicare options. The recent surge from 4,700 to more than 10,000 members is partly due to strategic expansion into Los Angeles, Riverside and San Bernardino counties. This expansion, effective from Jan. 1, 2024, is a crucial step in Astiva Health’s mission to offer increased access to healthcare for a wide demographic in Southern California.

“Our growth to over 10,000 members is a direct reflection of our commitment to personalized, culturally sensitive healthcare,” said Dr. Tri T. Nguyen, cofounder and CEO of Astiva Health. “By extending our services to these counties, we’re not just expanding our reach — we’re enhancing the healthcare experience for our members.”

Astiva is redefining healthcare standards by improving member services, medical care, prescription coverage, and supplemental benefits. The company also offers multilingual solutions and educational resources, ensuring all members receive effective and culturally attuned care.

“This increase in membership showcases Astiva Health’s robust, member-focused approach, building lasting relationships and meeting the unique needs of our members,” states Astiva Health. “It also reflects the community’s trust in us as their healthcare provider.”

Astiva Health is dedicated to innovative health plans that meet the unique requirements of its members, emphasizing a culturally responsive healthcare model and serving underserved populations. This not only addresses critical societal needs but positions Astiva to capitalize on significant market growth potential. Astiva Health’s goal is to foster lasting relationships and improve the overall well-being of the communities it serves.

For more information, visit the company’s website at www.AstivaHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

• Sigyn Therapeutics has designed a pipeline of medical technologies to improve cancer treatment outcomes by reducing the circulating presence of bloodstream particles that decoy or block the intended delivery of cancer therapies. At present, less than 2% of therapeutic antibodies and chemotherapy doses administered to cancer patients are delivered to tumor cell targets
• The company has also created a medical technology to reduce the circulating presence of off-target chemotherapy from the bloodstream to reduce patient toxicity and organ damage
• The company’s lead therapeutic candidate addresses life-threatening conditions that are pathogen-induced and not addressed with drug therapies

Sigyn Therapeutics (OTCQB: SIGYD, SIGY), a development-stage medical technology company creates therapeutic candidates with two prerequisites in mind: 1) they must offer to overcome a clearly defined limitation in global health, and 2) their successful clinical advancement would provide a potential competitive advantage within an established therapeutic industry segment.

The company’s therapeutic candidates include:

• Sigyn Therapy(TM) – to treat pathogen-associated conditions that are not addressed with FDA-approved drugs
• ImmunePrep(TM) – a platform to enhance the performance of therapeutic antibodies to treat cancer
• ChemoPrep(TM) – to improve the delivery of cancer chemotherapies
• ChemoPure(TM) – to reduce the post-treatment toxicity of chemotherapy

Sigyn Therapy(TM) is a novel blood purification technology being advanced to treat pathogen-associated inflammatory disorders. To date, in vitro studies have demonstrated the ability of Sigyn Therapy(TM) to reduce the circulating prevalence of twelve different pathogen and inflammatory disease targets from human blood plasma.  Based on these outcomes, candidate treatment indications include community-acquired pneumonia, endotoxemia, drug resistant viral and bacterial infections, and sepsis, the leading cause of hospital deaths in the United States.  First-in-human feasibility studies of Sigyn Therapy(TM) plan to enroll end-stage renal disease (“ESRD”) patients with endotoxemia and concurrent inflammation, which are highly prevalent and associated with increased mortality in the ESRD population.

ImmunePrep(TM) is a development-stage commercialization platform to enhance and extend the performance of immunotherapeutic antibodies, which account for nine of the top 15 best-selling cancer treatment drugs. ChemoPrep(TM) is designed to optimize the delivery of chemotherapy, the most commonly administered drug to treat cancer, while ChemoPure(TM) extracts off-target chemotherapy from the bloodstream to reduce patient toxicity.

Sigyn Therapeutics CEO, James A. Joyce, on the inspiration for ChemoPrep and ChemoPure stated, “They were designed to improve cancer patient outcomes and improve quality of life based on the unfortunate reality that a vast majority of chemotherapy is not delivered to intended tumor cell targets and off-target chemotherapy remaining in the bloodstream is more likely to contribute to patient toxicity versus therapeutic benefit.”

For more information, visit the company’s website at www.SigynTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to SIGY are available in the company’s newsroom at https://ibn.fm/SIGY

• Arizona-based SenesTech Inc., is dramatically improving pest management technicians’ toolbox with its patent-pending Evolve(R) soft bait birth control product for rodents
• SenesTech’s Evolve(R) product joins the liquid ContraPest(TM) product in providing a non-lethal solutions to reducing rodent populations
• The company’s CEO and CFO recently appeared virtually at the Lytham Partners 2024 Investor Select Conference, participating in a fireside chat interview and meeting one-on-one with potential investors
• SenesTech also recently announced increased distribution of its product in partnership with Poppe Enterprises LLC, — a company that serves the grain management market in Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa, and Colorado

The chief officers of enterprising rodent control company SenesTech (NASDAQ: SNES) participated in a fireside chat interview detailing the company’s operations and also met with potential investors one-on-one at this month’s virtual Lytham Partners 2024 Investor Select Conference.

CEO Joel Fruendt and CFO Tom Chesterman enjoyed the opportunity to discuss the breakout success of its non-lethal Evolve(TM) Soft Bait product following on the heels of successful implementation of its original liquid bait formulation ContraPest(R), which, like Evolve(TM), is designed to reduce rat populations by administering an ingestible birth control product that keeps rodents from proliferating.

The webcast of the Feb. 1 fireside interview is available on the company’s website at https://ibn.fm/q1K6P.

The patent-pending Evolve(TM) soft bait has a sausage-like appearance and poses little or no risk to human health or the environment — a significant advantage over poisons used to kill rats. SenesTech’s products are the first, and still the only, such rat contraceptives registered with the U.S. Environmental Protection Agency (“EPA”) that target both male and female rats.

And, while trapping and poisons may eliminate rodents quickly, leaving their carcasses to be cleaned up as evidence of their effectiveness, even a single breeding pair of surviving rodents can lead quickly to a new generation of up to 15,000 offspring after a single year, according to Fruendt.

The company recommends using its Birth Control for Rats(TM) products in tandem with other rodent control products, since rats that consume Evolve(TM) or ContraPest(R) will continue to live out their life cycles for months, just without adding new generations of pups. But SenesTech’s products can be used on their own if preferred.

“The most (effective approach) is combining the elements of integrated pest management, and having them work together and support each other. We have plenty of evidence that outcomes are improved over the baseline when ContraPest(R) is added to an integrated pest management program but, given enough time, the product will work (by) itself,” Fruendt said in a Q&A forum featured on SenesTech’s YouTube channel (https://ibn.fm/SIM5A).

The company’s reach is expanding globally — in addition to outlets across the United States, government entities in South Africa, the Maldives and, last month, the United Arab Emirates (“UAE”) market have entered agreements with the company.

On Jan. 29, SenesTech announced a distribution agreement with Poppe Enterprises LLC, which serves the grain management market in Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa, and Colorado (https://ibn.fm/CB2aQ).

“Grain storage operations have unique challenges when it comes to rodent pest control. Poisons are highly regulated and are tricky to use without contamination, and traps are expensive and time-consuming to maintain,” Fruendt stated. “Poppe Enterprises has a keen focus on innovation, safety, and sustainability, and a strong reputation in this substantial market.”

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

• SuperCom, a global provider of digital identity and electronic monitoring (“EM”) solutions, just announced a new project in the tracking sector with a renowned Canadian industry partner
• The initial phase of the project is set to launch in the first quarter of the 2024 calendar year, with significant potential for expansion in both scale and scope
• The project will include the transition from RF-based tracking technology to new GPS tech using SuperCom’s PureOne devices

SuperCom (NASDAQ: SPCB), a global leading provider of digital identity and electronic monitoring solutions and services to governments and institutions, just announced a new project with a renowned Canadian industry partner in the tracking solutions sector. This marks an impressive start to the new year and a healthy addition to SuperCom’s current client and project portfolio, comprising governments and notable institutions in over 10 countries (https://ibn.fm/pmZRq).

The new project comes in the wake of the growing realization that offender monitoring solutions reduce recidivism among offenders. In a study conducted by Jenny Williams and Don Weatherburn, it was established that electronic monitoring for offenders was associated with a 25% reduction in the likelihood of reoffending compared to serving time in prison. This is significant, especially since the average rate of reoffending within 24 months of free time is 58% for those who serve a prison sentence (https://ibn.fm/ScXzE).

SuperCom has been bullish on its electronic offender monitoring solutions. Having been keen on developing and improving it over the years, the Finnish government has adopted it, with positive results achieved from its usage. In addition, it has seen the products distributed in the U.S. market, an indicator of the growing demand and the overall value they offer. This new project in Canada marks a new chapter in the company’s long-standing collaboration with this partner. It will see the transition from successful collaboration for providing RF-based tracking technology to embracing new GPS technologies using SuperCom’s state-of-the-art PureOne devices.

“We’re excited about this new project in Canada,” noted Ordan Trabelsi, CEO and President of SuperCom. “This project not only strengthens our relationship with a valued partner but also highlights our commitment to innovation and adapting to market needs,” he added.

The project’s initial phase is set to launch in the first quarter of the 2024 calendar year, with significant potential for expansion in both scale and scope. For SuperCom, this collaboration is a testament to its enduring partnerships and capacity for future growth. It is also a testament to its ability to adapt to the evolving needs of its clients.

“We are proud to see the trust and confidence our partner has placed in us and our innovative tracking solutions,” noted Mr. Trabelsi. “This project exemplifies our dedication to delivering cutting-edge technology and reinforces our position as a leader in the electronic monitoring industry,” he concluded.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

• GEMXX recently announced insights into the burgeoning jewelry and colored gemstones markets in India
• The jewelry market in India is expected to grow by US$21.54 billion between 2023 and 2027, while the colored gemstones market is projected to reach $1.9 billion by 2033 from an estimated $707.8 million in 2024
• GEMXX, a leading producer of top-quality finished Ammolite, anticipates that this rare gemstone has the potential to attract a significant portion of buyers in India seeking something innovative or distinct from conventional colored gemstones
• The company is positioned to capitalize on the growing trend in the colored gemstones market, with its unmatched mine-to-market hold on high-quality Ammolite supplies, by offering a wide array of Ammolite products to cater to the evolving preferences of consumers in India

India’s colored gemstone industry has rebounded, witnessing a resurgence in demand after taking a hit during the pandemic in 2020. Multiple reasons have been advanced to explain the recovery, including the growing impact of social media, the middle-class population’s growing desire for a more luxurious lifestyle, improving standards of living, the traditional appreciation of jewelry as a store of wealth and a secure asset, plus general aesthetic reasons (https://ibn.fm/j4vO2).

“Beyond mere aesthetics, gemstones and gold in India hold a distinct significance for a substantial portion of the population, believed to possess almost divine powers. The demand for colored gemstones is also on the rise, driven by their perceived Vedic properties, making them more than just precious stones but also carriers of sentimental and astrological value,” wrote GEMXX (OTC: GEMZ) in a Jan. 31 press release announcing its insights into the burgeoning jewelry and colored gemstone markets in India (https://ibn.fm/lid3r).

A leading mine-to-market company, GEMXX controls every stage of its operations, from gold and gemstone extraction to jewelry production and worldwide distribution. The company is currently focused on mining and producing jewelry out of gold, a traditional safe-haven asset, and Ammolite, a rare gemstone with iridescent properties.

GEMXX had previously projected a promising future for gold, a commodity it forecasts will reach new highs in the coming 24 months (https://ibn.fm/C24Fq). In a more recent announcement, the company provided a similarly positive outlook covering India’s burgeoning markets for colored gemstones, of which Ammolite is part, and jewelry.

In the press release, GEMXX highlighted recent industry forecasts, which anticipate that the jewelry market in India will surge by US$21.54 billion between 2023 and 2027, representing an impressive CAGR of 5.54%. This growth, GEMXX holds, is positioning India as a key player in the global jewelry arena. The company also singled out the colored gemstones market in India, which analysts expect to reach $707.8 million in 2024 and US$1.9 billion by 2033, marking a robust 10.5% CAGR between 2023 and 2033.

“This industry forecast pinpointing the increase in demand for colored gemstones and gold allows investors a safe haven for investing in a company backed by gemstones and gold rather than a sometimes-volatile technology stock,” said Jay Maull, CEO of GEMXX Corp. “The growth rate of the colored gemstone market in India is surpassing the overall growth rate of the jewelry market in India by 2.1%.”

According to Maull, Ammolite, a relatively recent addition to the Indian colored gemstone market, has the potential to attract a significant portion of buyers seeking something innovative or distinct from conventional colored gemstones. Against this backdrop, GEMXX is positioned to take advantage of this growing trend by offering a wide array of ammolite products to cater to the evolving preferences of the Indian market.

“GEMXX stands out as the leading producer of top-quality finished Ammolite, surpassing all other competitors in terms of quality and production capacity,” the company says on its website (https://ibn.fm/nVFGt). These unique capabilities are expected to enable GEMXX to continue to innovate and provide unique gemstone options that resonate with not only the cultural practices but also the spiritual beliefs of consumers in India.

Those interested in participating through Reg A financing are encouraged to visit the company’s investor page (https://ibn.fm/Wj0Ci) or contact company officials for more information (ir@gemxx.com – 702-930-1815).

For more information, visit the company’s website at www.GEMXX.com/investors.

NOTE TO INVESTORS: The latest news and updates relating to GEMZ are available in the company’s newsroom at https://ibn.fm/GEMZ

• Utah-based Diamond Lake Minerals is developing its vision of an umbrella parent company that not only holds a variety of industry-crossing subsidiaries, but that also serves as a gateway for cautious investors looking to dip a toe into digital assets
• The company’s vertically integrated portfolio will include holdings that are infused with security token offerings registered with the U.S. Securities and Exchange Commission
• Diamond Lake views its digital asset-in-a-real world asset gateway as a hedge against market volatility, especially for real estate properties that may be over-leveraged and struggling to stay afloat while seeking favorable lending terms
• A recent spate of bad debt concerns in the commercial real estate arena has raised warnings about bank exposure and a possible run against uninsured financiers

Recent concerns about a global wave of commercial real estate loan defaults, described as potentially the worst crisis for the sector since the 2008 bursting of the global financial bubble, is leading banks to proactively assure investors about their ability to absorb potential losses, while investors scrutinize loan books for signs of insecurity (https://ibn.fm/v5SpF).

As investors worry, multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is pursuing a course that offers investors regulatory oversight in the digital asset market and a potential solution to “underwater” real estate property owners that could offset volatility in the market.

Diamond Lake CEO Brian J. Esposito commented on the company’s solution for helping people generate wealth from both digital and traditional securities in a Jan. 31 interview with Proactive Investors (https://ibn.fm/2BXza), highlighting the role real estate may play in the growth of fractional security token offering (“STO”) ownership of real assets.

“A lot of these properties are highly leveraged — they can be overvalued. And they’re sitting on balance sheets somewhere that have a potential risk factor, especially for banks that are holding this paper,” Esposito said. “It’s very hard to create liquidity for those building holders, or those property holders. So if you were to take that building that you couldn’t get rebank financing … on that property, but it does have the ability to earn and create value, well then you can open it up to millions of people around the world through a proper security token offering and (do) it under the right rules and regulations, where now you have all kinds of potential liquidity and capital coming in.”

Esposito said offsetting market volatility by opening commercial properties up to fractional ownership is Diamond Lake’s approach to creating a “giant funnel of liquidity and access to capital that was never able to be accessed before.”

The company is saying, “Hey, I don’t want to see the real estate market collapse, … because of all those assets in the trillions … that’s on balance sheets around the world,” he added. “If that starts to crumble, it hurts everybody — it hurts the local economy, it hurts the stock market.”

Diamond Lake is creating a powerful parent umbrella company with quality, industry-agnostic assets, and imbuing those vertically integrated subsidiaries with U.S. Securities and Exchange Commission (“SEC”)-registered STOs via the regulated security token exchange INX.

Diamond Lake’s gateway therefore is not only to the real asset holdings in sectors ranging from entertainment to real estate to health care and medicine, but also to the emerging market sector that digital assets comprise.

“We want to always create responsible business transactions. We like to do these things with seasoned entrepreneurs and professionals who’ve got great accounting and regulatory and compliance,” Esposito said. “Anything that’s a really good asset for our balance sheet and anything that we can create great profitability and returns for, that’s what we want under our DLMI umbrella.”

In addition, for information on the company’s security token SEC regulated exchange partner INX, and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.

For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

• The Activist Investor Conference will take place on March 21, 2024, at 237 Park Avenue, one of Manhattan’s premiere meeting venues
• The 14th annual edition of the conference features investors, corporate board members and governance experts, advisory firms, proxy solicitors and finance professionals who will delve into the latest trends within shareholder activism
• This year’s conference features a number of keynote presentations by experts in the field, including Patrice Bonfiglio, Sean Donohue, and Jon Feldman

Shareholder activism emerged in the 1970s and 1980s as a tool to drive the process of price formation, improve corporate governance and defend minority shareholder interests. Today, in a market environment characterized by a surge in the number of passive investors and a reduction in the diversity of research and market participants, the importance of shareholder activism may be greater than ever.

Corporate engagement and shareholder activism has become increasingly crucial within the context of modern financial markets.

With over 20 years of experience and having hosted over 200 conferences, seminars and webcasts on a variety of financial topics, DealFlow Events is gearing up to host the upcoming Activist Investor Conference 2024 on March 21, 2024 in New York City. Now in its 14th year, the Activist Investor Conference delivers an invaluable forum for discussion of governance-related issues by savvy finance professionals seeking to improve the fortunes of the companies in which they’ve invested.

Covering a wide range of topics, including ‘Value Investing’, ‘Trending Legal Issues Facing Shareholder Activism’, ‘How the Lone Dissident can Prevail’ and the ‘Impact of corporate relations with shareholders on an activist campaign’, the conference presents a slate of keynote presentations throughout the day. Speakers include Patrice Bonfiglio, President at Sarissa Capital; Sean Donohue, Co-Chair of Shareholder Activism and Takeover Defense at Paul Hastings LLP; Jon Feldman, Partner at Goodmans; Adam Kommel, Shareholder Activism Development Lead at Bloomberg LP; and Michael Levin, Founder of The Activist Investor, among several other experts in the field.

Conference attendees will be in an enviable position to hear key insights into the world of activist investing. Ranging from understanding the evolution of shareholder and management rights over time, to learning about board size, short attacks and activist strategy, investors will learn about what really matters within activist investing today as well as what to expect in the future.

For additional details about the Activist Investor Conference, including registration, visit: https://www.activistinvestorconference.com.